Understanding the impact of COVID-19 on quality of life using surveys and Mendelian randomization.

Understanding the impact of COVID-19 on quality of life using surveys and Mendelian randomization.

Publication date: Dec 28, 2024

The COVID-19 pandemic has significantly impacted the quality of life (QoL) of individuals in China, affecting both their physical and mental well-being. This study aims to comprehensively analyze the factors influencing QoL in China during the pandemic. In 2022, we collected data using a self-developed questionnaire (dataset 2) and obtained dataset 1 from the 2021 China General Social Survey (CGSS). After confirming the scale’s reliability and validity, we employed a random forest algorithm to prioritize the factors. Subsequently, Mendelian randomization analyses were conducted using data from the MRC IEU OpenGWAS data infrastructure. By comparing data from two periods with low and high infection rates, the results showed that among the various influences brought about by the prevalence of COVID-19, sleep disorders have a significant and widespread impact on the quality of life, especially for the elderly. Through the inclusion of Mendelian randomization analysis, we found that COVID-19 have a relative increase in the risk of developing insomnia by approximately 26. 7% (OR = 1. 267). These findings can inform the development of targeted interventions and strategies to improve overall well-being.

Open Access PDF

Concepts Keywords
China Adolescent
Mendelian Adult
Pandemic Aged
Sleep China
COVID-19
COVID-19
Female
Humans
Machine learning
Male
Mendelian randomization
Mendelian Randomization Analysis
Mental health
Middle Aged
Pandemics
Quality of Life
Quality of life
SARS-CoV-2
SF-12 scale
Sleep disorder
Surveys and Questionnaires
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease IDO quality
disease IDO algorithm
disease MESH infection
disease MESH sleep disorders
disease MESH insomnia
drug DRUGBANK Coenzyme M
disease MESH complications
disease MESH death
disease MESH anosmia
disease MESH ageusia
disease MESH hair loss
disease IDO history
disease MESH anxiety
disease MESH depression
disease MESH uncertainty
disease MESH mental disorders
disease MESH emergencies
disease MESH coronavirus infection
disease MESH psychological distress
disease IDO process
disease MESH chronic diseases
disease MESH liver diseases
disease MESH digestive system diseases
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO susceptibility
disease MESH dyslipidemia
disease MESH respiratory diseases
drug DRUGBANK Pidolic Acid
disease MESH psychological well being
disease MESH sleep deprivation
disease MESH respiratory infections
disease MESH sleep quality
disease MESH loneliness
disease IDO nucleic acid
disease IDO immune response
disease IDO cell
disease MESH autoimmune diseases
disease IDO country
disease MESH daytime sleepiness
disease MESH influenza
disease MESH morbidities
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)